Pharmascroll Research and Consulting Pvt Ltd

Pharmascroll Research and Consulting Pvt Ltd is a single-minded analytical team that specializes in consulting services across the global healthcare sector.

The core area of their activity is the research of the pharmaceutical industries, in particular, the medications for the widespread chronic illnesses. Medical specialists and pharmacologists can request all types of research on the issues concerning their business. The outcome of the Pharmascroll’s team is a comprehensive analysis of the latest indications together with succinct information analysis product.

Pharmascroll’s reports contain logical conclusions, reliable data, and viable solutions. Depending on the customer’s objectives, the research can be primary, secondary or combined.

The experts meticulously study credible information sources such as:
  • Scientific journals
  • Industry publications
  • Manufacturers’ offerings
  • Product portfolios
  • Financial surveys
  • News items
  • Investment insights
The company’s specialists qualified in the management, pharmaceutical, and statistical areas conduct the research to gather intelligence to ensure the client’s business growth in the industry.

Research Reports By Pharmascroll Research and Consulting Pvt Ltd

Found 66 publications
Alzheimer’s: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Schizophrenia: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
COPD: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Depression: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Parkinson's: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Asthma: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
COPD: Disease Inights and Market Forecasts to 2024 US$ 5,000.00 Apr, 2018 120 pages
COPD: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Depression: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Asthma: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Epilepsy: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
ADHD: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Schizophrenia: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
COPD: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Cystic Fibrosis: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Parkinson's: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Asthma: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Asthma: Disease Inights and Market Forecasts to 2024 US$ 5,000.00 Apr, 2018 120 pages
Epilepsy: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Rhinitis: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Alzheimer's: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Epilepsy: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Rhinitis: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Cystic Fibrosis: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Migraine- Detailed overview Acute Treatments US$ 4,000.00 Jan, 2018 87 pages
Migraine- A Detailed overview US$ 5,000.00 Jan, 2018 125 pages
Migraine- Disease overview and Epidemiology US$ 2,000.00 Jan, 2018 30 pages
Migraine- Disease overview US$ 1,000.00 Jan, 2018 21 pages
Migraine- Detailed overview Prophylactic Treatments US$ 4,000.00 Jan, 2018 90 pages
SPMS- Disease Overview US$ 1,000.00 Oct, 2017 18 pages
PPMS- France Overview US$ 3,000.00 Oct, 2017 73 pages
SPMS- Spain Overview US$ 3,000.00 Oct, 2017 78 pages
PPMS- Disease Overview US$ 1,000.00 Oct, 2017 20 pages
1 2
Skip to top

Analytics & News by Pharmascroll Research and Consulting Pvt Ltd